Bortezomib and Hallucinations - a phase IV clinical study of FDA data
Summary:
Hallucinations is reported as a side effect among people who take Bortezomib (bortezomib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Sertraline, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Hallucinations when taking Bortezomib. It is created by eHealthMe based on reports of 30,902 people who have side effects when taking Bortezomib from the FDA, and is updated regularly.
What is Bortezomib?
Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.
What is Hallucinations?
Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,893 drugs and 2,727 conditions by eHealthMe. Check the latest studies of Hallucinations.
30,902 people reported to have side effects when taking Bortezomib.
Among them, 107 people (0.35%) have Hallucinations.
Among these 107 people:
How long have people been on Bortezomib when they have Hallucinations? *
What is the gender of people who have Hallucinations when taking Bortezomib? *
What is the age of people who have Hallucinations when taking Bortezomib? *
What are other drugs people take besides Bortezomib? *
What are other side effects people have besides Hallucinations? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Bortezomib and have Hallucinations?
- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Bortezomib:
- Bortezomib (30,912 reports)
Hallucinations treatments and more:
- Hallucinations (98,683 reports)
How severe was Hallucinations and when was it recovered:
Expand to all the drugs that have ingredients of bortezomib:
- Hallucinations and drugs with ingredients of bortezomib (299 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bortezomib:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hallucinations:
- Hallucinations (1,893 drugs)
Browse all the conditions that are associated with Hallucinations:
- Hallucinations (2,727 conditions)
Related publications that referenced our studies
- Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
- Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
- Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
- Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on bortezomib (the active ingredients of Bortezomib) and Bortezomib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flurazepam Hydrochloride vs. Geodon, side effect and effectiveness comparison - 8 seconds ago
- Actiq vs. Diazepam, side effect and effectiveness comparison - 9 seconds ago
- Small Cell Lung Cancer Metastatic and Pancytopenia - 9 seconds ago
- Drug interactions of Acyclovir and Zicam - 11 seconds ago
- Drug interactions of Apple Cider Vinegar and Trulicity - 13 seconds ago
- Death and drugs of ingredients of penicillin v potassium - 18 seconds ago
- Metoprolol Succinate and Fosamax drug interactions for women aged 60+ - 23 seconds ago
- Drug interactions of Xolair and Vitamin B12 - 32 seconds ago
- Could Metoprolol Succinate cause Dermatitis Bullous? - 37 seconds ago
- Divalproex vs. Equetro, side effect and effectiveness comparison - 43 seconds ago